Innovating Works

filtrando por convocatoria: HORIZON-JU-GH-EDCTP3-2024-Mpox

MBOTE-SK: Tackling and investigating the South-Kivu mpox outbreak INSTITUUT VOOR TROPISCHE GENEESKUNDE tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox With the Mpox Biology, Outcome, Transmission, and Epidemiology in South Kivu (MBOTE-SK) project, we seek emergency funding to address one of...
2024-08-01 - 2027-01-31 | Financiado
ODIN-MPox: Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa LUNDS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox, a re-emerging viral zoonotic disease, has recently posed significant public health challenges in sub-Saharan Africa, particularly in t...
2024-08-01 - 2026-07-31 | Financiado
PREGMPOX: Impact of MPXV infection on pregnancy outcome and newborn health UNIVERSITEIT ANTWERPEN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Pregnant women have an increased risk of severe mpox disease, however, the underlying mechanisms remain elusive. To better understand altere...
2024-08-01 - 2027-07-31 | Financiado
PregInPoxVac: MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF... UNIVERSITEIT ANTWERPEN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox can cause severe complications in vulnerable groups such as pregnant women and children, necessitating targeted public health intervent...
2024-08-01 - 2027-07-31 | Financiado
PREGMPOX: Impact of MPXV infection on pregnancy outcome and newborn health Pregnant women have an increased risk of severe mpox disease, however, the underlying mechanisms remain elusive. To better understand altere...
2024-07-26 - 2027-07-31 | Financiado
MpoxVax AFRIVAC: Expanding a prospective clinical trial examining the immune response of participants receiving Modi... The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and ov...
2024-10-03 - 2027-03-31 | Financiado
PregInPoxVac: MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3 OPEN LABEL RANDOMISED VACCINE TRIAL OF... Mpox can cause severe complications in vulnerable groups such as pregnant women and children, necessitating targeted public health intervent...
2024-08-26 - 2027-07-31 | Financiado
MPOX-PROBE: Strengthening epidemiological genomic and community surveillance of Mpox virus MPXV at the Congo... The spread of Mpox virus (MPXV) in Sub-Saharan Africa, specifically Democratic Republic of Congo (DRC) and Republic of Congo (RoC) presents...
2024-09-27 - 2026-09-30 | Financiado
DECIPHER-MPOX: Deciphering host genetics and viral determinants of MPOX epidemiology in the Democratic Republic of... Background: Monkeypox virus (MPV) is a member of the Poxviridae family that includes smallpox, cowpox and chickenpox viruses. Endemic to equ...
2024-08-09 - 2026-07-31 | Financiado
ODIN-MPox: Implementing wastewater and environmental surveillance for Mpox in Sub Saharan Africa LUNDS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox, a re-emerging viral zoonotic disease, has recently posed significant public health challenges in sub-Saharan Africa, particularly in t...
2024-08-07 - 2026-07-31 | Financiado
MBOTE-SK: Tackling and investigating the South Kivu mpox outbreak INSTITUUT VOOR TROPISCHE GENEESKUNDE tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox With the Mpox Biology, Outcome, Transmission, and Epidemiology in South Kivu (MBOTE-SK) project, we seek emergency funding to address one of...
2024-07-29 - 2027-01-31 | Financiado